asthma. J45.0
Conditions
Interventions
Intervention 1: For 34 children will be administered Montelukast tablet 5 mg daily till one month after the baseline visit. Intervention 2: for 34 children Fluticasone spray 100 mcg 2 puffs twice a d
Treatment - Drugs
For 34 children will be administered Montelukast tablet 5 mg daily till one month after the baseline visit
for 34 children Fluticasone spray 100 mcg 2 puffs twice a day for 1 month and adjust the dose will be done after one month visit.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 5 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: children under 5 years, with more than 3 times the number of wheezing in clinical studies and no clinical evidence of other predisposing factors. Exclusion criteria: children under 5 years who have evidence of other predisposing factors for wheezing, such as Gastro Esophageal Reflux Disease, Cystic Fibrosis, heart disease, airway disease, congenital anatomical issues.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wheeze severity. Timepoint: before intervention and every month after intervention till 6 month. Method of measurement: physical examination and listen breath sounds. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cough severity. Timepoint: before intervention and every month after intervention till 6 month. Method of measurement: physical examination and ask from parents.;Dyspnea severity. Timepoint: before intervention and every month after intervention till 6 month. Method of measurement: physical examination and ask from parents. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Mahnaz Sadeghi Shabestari
Medical Faculty
Outcome results
None listed